CD4 and Cirrhosis: Coinfected patients remain at a greater risk for HCV disease progression than patients with HCV monoinfection, with an accelerated progression of liver disease leading to cirrhosis and hepatic decompensation; the risk of progression is even greater in coinfected patients with low CD4 T lymphocyte (CD4) cell counts [2–4].